United States · FDA National Drug Code directory
Clindamycin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-144_1420c437-e47e-4757-9b4c-3c8ad8a936bb
- Product NDC
- 68462-144
- Form
- CAPSULE
- Composition / generic term
- Clindamycin Hydrochloride
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230310
- Source listing expiry
- 20271231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68462-144-01) · 68462-144-01
- 3 BLISTER PACK in 1 CARTON (68462-144-81) / 20 CAPSULE in 1 BLISTER PACK · 68462-144-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →